News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing: 1–36
Matches: 98
Sources here: 13
Companies here: 11

Search results Stored financial headlines Latest headline 12:35, 13 August 2026

Active search

98 matching headlines

Ticker or company: ZEALMain company stories

Clear

Latest12:35 · 13 August 2026

finance.yahoo.com Earnings

Zealand Pharma A/S (ZLDPF) Surpasses Q2 Earnings and Revenue Estimates

Zealand Pharma A/S (ZLDPF) came out with quarterly earnings of $8.61 per share, beating the Zacks Consensus Estimate of a loss of $0.42 per share. This compares to earnings of $16.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +2,150.00%. A quarter ago, it was expected …

Main company 🇩🇰 Denmark

Read at finance.yahoo.com

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

Just inNext headlines

09:10 13 Aug 2026

finance.yahoo.com Earnings Main company 🇩🇰 Denmark

Zealand Pharma (CPSE:ZEAL) Stock Looks Fairly Valued After Its 90% Five Year Run

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Zealand Pharma stock has delivered a strong 90.3% return over the past five years, yet its low overall value score and current market multiples suggest the shares …

ZEAL main company ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

06:00 13 Aug 2026

finance.yahoo.com Regulatory and legal Main company 🇩🇰 Denmark

Zealand Pharma Announces Financial Results for the First Half of 2026

Zealand Pharma Company announcement – No. 39 / 2026 Zealand Pharma Announces Financial Results for the First Half of 2026 A landmark first half defined by key milestones delivered for leading obesity assets, and a continued momentum building across all fronts of our Metabolic …

ZEAL main company ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

00:16 13 Aug 2026

finance.yahoo.com Earnings Main company 🇩🇰 Denmark

Zealand Pharma (CPSE:ZEAL) On Its Royalty Pharma Deal And The Fair Value Debate

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Why Zealand Pharma stock is in focus after the Royalty Pharma deal Zealand Pharma (CPSE:ZEAL) has drawn fresh attention after agreeing to a US$100 million royalty purchase …

ZEAL main company ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

21:10 12 Aug 2026

finance.yahoo.com Market update Main company 🇩🇰 Denmark

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million

Royalty Pharma plc NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced an agreement for $100 million in funding to Zealand Pharma in exchange for Zealand Pharma's economics related to rusfertide (PTG-300), a potential first-in-class therapy for polycythemia …

ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

21:05 12 Aug 2026

finance.yahoo.com Regulatory and legal Main company 🇩🇰 Denmark

Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

Zealand Pharma Company announcement – No. 38 / 2026 Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma will receive USD 100 million for the sale of its economic …

ZEAL main company ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

09:44 12 Aug 2026

simplywall.st Market update Main company 🇳🇿 New Zealand

Millennium & Copthorne Hotels New Zealand (NZSE:MCK) Stock Faces Sharp Valuation Disconnect

MCK main company

Sharemaestro market context Price below Trend Line 52 weeks +9.0%

08:38 11 Aug 2026

Kalkine Market update Main company 🇳🇿 New Zealand

New Zealand King Salmon Investments (ASX:NZK) Shares Surge in Active Trading

NZK main company

Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup negative 30.5%

05:31 11 Aug 2026

marketscreener.com Earnings Main company 🇳🇿 New Zealand

Millennium & Copthorne Hotels New Zealand H1 Earnings, Revenue Up; Shares Jump 3%

MCK main company

Sharemaestro market context Price below Trend Line 52 weeks +9.0%

05:29 11 Aug 2026

Kalkine Earnings Main company 🇳🇿 New Zealand

New Zealand King Salmon (ASX:NZK) Rises After Earnings Recovery Takes Hold

NZK main company

Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup negative 30.5%

03:59 11 Aug 2026

TipRanks Market update Main company 🇳🇿 New Zealand

South Port New Zealand Sets 2026 AGM Date and Opens Director Nominations

SPN main company

Sharemaestro market context Price above Trend Line 52 weeks +16.1%

03:22 11 Aug 2026

Kalkine Earnings Main company 🇳🇿 New Zealand

Why Did Millennium & Copthorne Hotels New Zealand (NZX:MCK) Lift Profit in 2026? Key Growth Drivers Explained

MCK main company

Sharemaestro market context Price below Trend Line 52 weeks +9.0%

20:44 10 Aug 2026

simplywall.st Earnings Main company 🇳🇿 New Zealand

CDL Investments New Zealand (NZSE:CDI) Stock Faces Lingering Margin Compression

CDI main company

Sharemaestro market context Price below Trend Line 52 weeks -15.4% · Next-week setup positive 59.1%

16:00 10 Aug 2026

finance.yahoo.com Capital return Main company 🇩🇰 Denmark

Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)

Zealand Pharma Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or "Zealand Pharma") (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future …

ZEAL main company ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

06:31 10 Aug 2026

Market source Market update Main company 🇳🇿 New Zealand

New Zealand Shares Rise; Contact Energy Fiscal 2026 EPS, Revenue Down

NZK main company

Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup negative 30.5%

03:20 10 Aug 2026

marketscreener.com Earnings Main company 🇳🇿 New Zealand

CDL Investments New Zealand Limited Reports Earnings Results for the Half Year Ended June 30, 2026

CDI main company

Sharemaestro market context Price below Trend Line 52 weeks -15.4% · Next-week setup positive 59.1%

00:47 10 Aug 2026

TipRanks Earnings Main company 🇳🇿 New Zealand

CDL Investments posts softer first-half profit, lifts asset backing

CDI main company

Sharemaestro market context Price below Trend Line 52 weeks -15.4% · Next-week setup positive 59.1%

22:55 9 Aug 2026

TipRanks Earnings Main company 🇳🇿 New Zealand

South Port Sets Date for FY26 Results and Investor Call

SPN main company

Sharemaestro market context Price above Trend Line 52 weeks +16.1%

07:40 8 Aug 2026

simplywall.st Market update Main company 🇦🇹 Austria

ZEAL Network SE (ETR:TIMA) hat soeben seine Ergebnisse für das erste Quartal veröffentlicht, und Analysten passen ihre Prognosen an

TIMA main company TIMA main company

Sharemaestro market context Stored weekly price path 18 weeks -8.6% · Next-week setup negative 44.1%

01:46 7 Aug 2026

marketscreener.com Balance sheet Main company 🇳🇿 New Zealand

CDL Investments New Zealand Unit Enters NZ$20 Million Credit Facility With ANZ Bank

CDI main company

Sharemaestro market context Price below Trend Line 52 weeks -15.4% · Next-week setup positive 59.1%

16:00 6 Aug 2026

finance.yahoo.com Earnings Main company 🇩🇰 Denmark

Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results

Zealand Pharma Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company …

ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

10:40 6 Aug 2026

it boltwise Analyst action Main company 🇦🇹 Austria

ZEAL Network: Starker Q2-Schub hebt EBITDA-Prognose – Analyst sieht BUY mit 83 Euro

TIMA main company TIMA main company

Sharemaestro market context Stored weekly price path 18 weeks -8.6% · Next-week setup negative 44.1%

10:05 5 Aug 2026

4investors.de Market update Main company 🇦🇹 Austria

ZEAL Network steigert Umsatz und Gewinn - „hervorragende Voraussetzungen”

TIMA main company TIMA main company

Sharemaestro market context Stored weekly price path 18 weeks -8.6% · Next-week setup negative 44.1%

08:05 5 Aug 2026

MarketScreener Deutschland Market update Main company 🇦🇹 Austria

ZEAL Network SE legt Ergebnisse für das zweite Quartal und das erste Halbjahr bis zum 30. Juni 2026 vor

TIMA main company TIMA main company

Sharemaestro market context Stored weekly price path 18 weeks -8.6% · Next-week setup negative 44.1%

08:00 5 Aug 2026

Moomoo Earnings Main company 🇳🇿 New Zealand

New Zealand Shares Fall; New Zealand King Salmon Investments Lifts Fiscal Year 2026 Earnings Guidance

NZK main company

Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup negative 30.5%

06:33 5 Aug 2026

FinanzNachrichten.de Market update Main company 🇦🇹 Austria

EQS-News: ZEAL Network SE: ZEAL wächst weiter und erzielt höchsten Halbjahresumsatz der Unternehmensgeschichte

TIMA main company TIMA main company

Sharemaestro market context Stored weekly price path 18 weeks -8.6% · Next-week setup negative 44.1%

09:43 4 Aug 2026

simplywall.st Market update Main company 🇳🇿 New Zealand

Spark New Zealand (NZSE:SPK) Following Digital Services Review Is The Undervalued Case Changing

SPK main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 43.5%

16:00 3 Aug 2026

finance.yahoo.com Capital return Main company 🇩🇰 Denmark

Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)

Zealand Pharma Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ("the Company" or "Zealand Pharma") (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future …

ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

08:00 3 Aug 2026

TipRanks Deals and strategy Main company 🇳🇿 New Zealand

Salt Funds Management Lifts Stake in New Zealand Rural Land Co.

NZL main company

Sharemaestro market context Price below Trend Line 52 weeks -8.6%

08:00 31 Jul 2026

Kalkine Capital return Main company 🇳🇿 New Zealand

Can Spark New Zealand’s (ASX:SPK) Dividend Appeal Continue Amid a Changing Telecom Landscape?

SPK main company SPK main company

Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 43.5%

08:00 31 Jul 2026

Kalkine Market update Main company 🇳🇿 New Zealand

New Zealand King Salmon (ASX:NZK): Shares Slide 5%: What's Happening in Aquaculture?

NZK main company

Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup negative 30.5%

20:09 29 Jul 2026

TradingView Market update Main company 🇳🇿 New Zealand

New Zealand Rural Land Co. Ltd. Revenue Breakdown – NZX:NZL

NZL main company

Sharemaestro market context Price below Trend Line 52 weeks -8.6%

08:00 28 Jul 2026

Market source Market update Main company 🇳🇿 New Zealand

New Zealand Shares at All-Time High; ikeGPS Group Posts Flat Fiscal Q1 Revenue

NZK main company

Sharemaestro market context Trend signal active 52 weeks +17.1% · Next-week setup negative 30.5%

16:00 27 Jul 2026

finance.yahoo.com Capital return Main company 🇩🇰 Denmark

Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)

Zealand Pharma Company announcement No. 35 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) Copenhagen, Denmark, July 27, 2026 – Zealand Pharma A/S ("the Company" or "Zealand Pharma") (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future …

ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%

08:00 27 Jul 2026

The Motley Fool Australia Deals and strategy Main company 🇦🇺 Australia

Spark New Zealand launches strategic review of Digital Services and updates structure

SPK main company

Sharemaestro market context Price below Trend Line 52 weeks -25.4% · Next-week setup negative 38.5%

21:00 20 Jul 2026

finance.yahoo.com Market update Main company 🇩🇰 Denmark

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Zealand Pharma Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or "Zealand Pharma") (Nasdaq: ZEAL) (CVR-no. …

ZEAL main company ZEAL main company

Sharemaestro market context Price above Trend Line 52 weeks -22.9%